Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Sell
4,572
-51
-1% -$3.4K 0.01% 619
2026
Q1
$290K Buy
4,623
+926
+25% +$64.5K 0.01% 614
2025
Q4
$245K Buy
3,697
+2,384
+182% +$154K 0.01% 642
2025
Q3
$88K Sell
1,313
-1,556
-54% -$123K ﹤0.01% 842
2025
Q2
$250K Sell
2,869
-894
-24% -$70.1K 0.01% 556
2025
Q1
$257K Sell
3,763
-140
-4% -$11.4K 0.01% 518
2024
Q4
$304K Buy
3,903
+3,380
+646% +$250K 0.01% 439
2024
Q3
$35.1K Sell
523
-1,819
-78% -$149K ﹤0.01% 551
2024
Q2
$266K Sell
2,342
-75
-3% -$9.48K 0.01% 484
2024
Q1
$335K Buy
2,417
+112
+5% +$14.1K 0.02% 429
2023
Q4
$286K Buy
+2,305
New +$235K 0.02% 417
2023
Q3
Sell
-2,271
Closed -$292K 493
2023
Q2
$292K Buy
2,271
+100
+5% +$12.1K 0.02% 434
2023
Q1
$251K Buy
+2,171
New +$243K 0.01% 437
2022
Q3
Sell
-37
Closed -$3K 641
2022
Q2
$3K Buy
+37
New +$3.38K ﹤0.01% 1063
2021
Q4
Sell
-356
Closed -$49K 485
2021
Q3
$49K Buy
356
+80
+29% +$10.1K ﹤0.01% 581
2021
Q2
$29K Buy
276
+168
+156% +$16.1K ﹤0.01% 665
2021
Q1
$10K Buy
108
+8
+8% +$751 ﹤0.01% 761
2020
Q4
$9K Buy
100
+92
+1,150% +$8.21K ﹤0.01% 733
2020
Q3
$1K Buy
+8
New +$836 ﹤0.01% 838

Other funds holding DXCM

CX Institutional's DXCM Position: Q2 2026 in Review

CX Institutional reduced its DexCom (DXCM) stake by 1.1% in Q2 2026, selling an estimated $3.4K and leaving 4,572 shares worth $308K. The position accounts for 0.01% of the portfolio, ranked #619.

CX Institutional first reported a position in DXCM in Q3 2020 and has held it in 19 quarters since. The position peaked at $335K in Q1 2024. 171 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • CX Institutional held 4,572 shares of DexCom worth $308K as of Q2 2026.
  • CX Institutional sold 51 DexCom shares in Q2 2026, an estimated $3.4K.
  • DexCom made up 0.01% of CX Institutional's portfolio in Q2 2026, its #619 holding.
  • CX Institutional first reported a position in DexCom in Q3 2020 and has held it in 19 quarters since.
  • CX Institutional's DexCom position peaked at $335K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.